Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SGLT2 inhibitor
SGLT2 inhibitor
FDA urged to increase safety warnings on common diabetes drug
Beckers Hospital Review
Thu, 06/25/20 - 10:48 am
Public Citizen
diabetes
citizen petitions
SGLT2 inhibitor
type 1 diabetes
How One Class Of Diabetes Medications May Lead To Flesh-Eating Genital Infections
Forbes
Mon, 09/3/18 - 12:02 pm
FDA
type 2 diabetes
SGLT2 inhibitor
Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes
Endpoints
Thu, 12/21/17 - 10:07 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
tugliflozin
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
diabetes
Merck
Pfizer
SGLT2 inhibitor
Januvia
Invokana
Farxiga
Jardiance
Eli Lilly
Boehringer Ingelheim
AstraZeneca
JNJ
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Fierce Pharma
Mon, 03/20/17 - 10:57 am
AstraZeneca
JNJ
Eli Lilly
Boehringer Ingelheim
diabetes
Farixga
Invokana
Jardiance
SGLT2 inhibitor
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
ertugliflozin
Jardiance
Boehringer Ingelheim
Eli Lilly
JNJ
Invokana
AstraZeneca
Farxiga
Lilly, BI step closer to a new heart-risk marketing push on Jardiance
Fierce Pharma Marketing
Wed, 01/27/16 - 04:12 pm
Eli Lilly
Boehringer Ingelheim
diabetes
Jardiance
SGLT2 inhibitor
Theracos raises $25M to take on Big Pharma in diabetes
Fierce Biotech
Sat, 01/16/16 - 11:39 am
Theracos
diabetes
SGLT2 inhibitor
Bad News Type 2 Diabetics: The FDA Is Out With Another Warning
Motley Fool
Mon, 09/7/15 - 11:38 am
FDA
type 2 diabetes
DPP-4 inhibitor
SGLT2 inhibitor
Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?
Motley Fool
Sun, 08/30/15 - 11:54 am
Merck
clinical trials
Januvia
Janumet
Eli Lilly
Boehringer Ingelheim
SGLT2 inhibitor
Jardiance
FDA's SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
Fierce Pharma
Mon, 05/18/15 - 09:40 pm
FDA
SGLT2 inhibitor
AstraZeneca
JNJ
Eli Lilly
Merck
diabetes
FDA warns on newer class of type 2 diabetes drugs
Yahoo/Reuters
Sat, 05/16/15 - 02:04 pm
FDA
diabetes
type 2 diabetes
AstraZeneca
Farxiga
Eli Lilly
Jardiance
Boehringer Ingelheim
JNJ
Invokana
SGLT2 inhibitor
J&J's Invokana fends off new SGLT2 rivals to hit $278M in Q1
Fierce Pharma Marketing
Wed, 04/15/15 - 09:28 am
JNJ
Invokana
SGLT2 inhibitor
diabetes
Boehringer Ingelheim
Eli Lilly
Jardiance
Glyxambi
This is Why Diabetes Treatment Costs Are Soaring
Motley Fool
Sat, 03/21/15 - 10:45 am
diabetes
SGLT2 inhibitor
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD
Yahoo
Thu, 03/5/15 - 08:49 am
patents
Islet Sciences
SGLT2 inhibitor
NASH
NAFLD
Eli Lilly and BI's Jardiance hits shelves
Medical Marketing and Media
Fri, 08/29/14 - 08:00 am
Eli Lilly
Jardiance
Boehringer Ingelheim
diabetes
SGLT2 inhibitor
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
SGLT2 inhibitor
Forxiga
Invokana
empagliflozin
What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool
Wed, 02/6/13 - 08:34 am
diabetes
Merck
SGLT2 inhibitor
Bristol-Myers Squibb
AstraZeneca
JNJ
Array Biopharma
Januvia
Amgen
Forixga
GKAs
Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union
Yahoo/AP
Thu, 11/15/12 - 10:46 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Europe
SGLT2 inhibitor
Forxiga
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thu, 11/15/12 - 10:45 am
diabetes
JNJ
Merck
Bristol-Myers Squibb
AstraZeneca
SGLT2 inhibitor
Pages
1
2
next ›
last »